Bismuth Subsalicylate 262 Mg Tablet, Chewable
NDC Package 69618-029-03

11-digit billing NDC: 69618002903 · Billing unit: EA · 30 EA per package

Package Information

Bismuth Subsalicylate 262 Mg (bismuth subsalicylate) tablets is drink plenty of clear fluids to help prevent dehydration caused by diarrhearepeat dosage every 1/2 to 1 hour as neededdo not take more than 8 doses in 24 hoursuse until diarrhea stops but not more than 2 daysadults and children 12 years and over: 2 tablets children under 12 years: ask a doctor. This formulation utilizes a tablet, chewable delivery system. Marketed by Reliable 1 Laboratories Llc, this product is identified by NDC 69618-029 and is authorized under FDA application M008.

Identification & Billing

NDC Package Code
69618-029-03
Package Description
30 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC
Product Code
11-Digit Billing Format
69618002903
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
30 EA
RxNorm Crosswalk
RxCUI: 308761 - bismuth subsalicylate 262 MG Chewable Tablet

Clinical Specifications

Proprietary Name
Bismuth Subsalicylate 262 Mg
Non-Proprietary Name
Bismuth Subsalicylate
Substance Name
Bismuth Subsalicylate
Dosage Form
Tablet, Chewable - A solid dosage form containing medicinal substances with or without suitable diluents that is intended to be chewed, producing a pleasant tasting residue in the oral cavity that is easily swallowed and does not leave a bitter or unpleasant after-taste.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
Drink plenty of clear fluids to help prevent dehydration caused by diarrhearepeat dosage every 1/2 to 1 hour as neededdo not take more than 8 doses in 24 hoursuse until diarrhea stops but not more than 2 daysadults and children 12 years and over: 2 tablets children under 12 years: ask a doctor

Regulatory & Marketing

Labeler Name
Reliable 1 Laboratories Llc
Product Type
Human Otc Drug
FDA Application #
M008
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
11-01-2015
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69618-029-03 identifies a specific commercial package of 30 tablet, chewable in 1 bottle, plastic of Bismuth Subsalicylate 262 Mg, a human over the counter drug labeled by Reliable 1 Laboratories Llc. This tablet, chewable is formulated for oral use and contains bismuth subsalicylate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Reliable 1 Laboratories Llc on November 01, 2015. The current certification is valid through December 31, 2026.

How is this Reliable 1 Laboratories Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69618002903. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
69618-029-03
11-Digit CMS (5-4-2)
69618-0029-03

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.